Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Kloke, O' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 23 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kloke, O
      Chemotherapy of elderly patients with non-small-cell lung cancer

      ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE
    2. Stahel, R; Purkalne, G; Herrstedt, J; Jelic, S; Fervers, B; Kloke, O; Mellstedt, H; Pavlidis, N; Jost, L
      ESMO Minimum Clinical Recommendations - the beginning of a process

      ANNALS OF ONCOLOGY
    3. Kloke, M; Rapp, M; Bosse, B; Kloke, O
      Toxicity and/or insufficient analgesia by opioid therapy: risk factors andthe impact of changing the opioid. A retrospective analysis of 273 patients observed at a single center

      SUPPORTIVE CARE IN CANCER
    4. Kloke, O; Opalka, B; Niederle, N
      Interferon alfa as primary treatment of chronic myeloid leukemia: long-term followup of 71 patients observed in a single center

      LEUKEMIA
    5. Adamietz, A; Beck, D; Gralow, I; Grond, S; Hanekop, G; Hankemeier, U; Heidemann, E; Hoffmann, L; Jage, J; Kath, R; Klaschik, E; Kloke, M; Kloke, O; Lempa, M; Lindena-Glaess, G; Nauck, F; Radbruch, L; Sohn, W; Strumpf, M; Tietze-Schillings, G; Tronnier, V; Weber, M; Zeilhofer, HU
      Guidelines for cancer pain therapy

      TUMORDIAGNOSTIK & THERAPIE
    6. Kloke, O; Klaassen, U; Oberhoff, C; Hartwich, G; Szanto, J; Wolf, E; Heckmann, M; Huhn, R; Stephan, L; Schnepper, U; Donsbach, GM; Bechtel, C; Rudolph, R; Berke, A; Borquez, D; Hawig, I; Hirche, H; Schindler, AE; Seeber, S; Becher, R
      Maintenance treatment with medroxyprogesterone acetate in patients with advanced breast cancer responding to chemotherapy: results of a randomized trial

      BREAST CANCER RESEARCH AND TREATMENT
    7. LAUTERMANN J; ADAMCZYK M; TENCATE WJF; KLOKE O
      CARBOPLATIN-INDUCED HEARING-LOSS

      Laryngo-, Rhino-, Otologie
    8. NOWROUSIAN MR; WELT A; FOSSA A; KASPER C; SCHRODER J; KUHLMANN S; SCHUTTE J; KLOKE O; STUSCHKE M; SCHULEHEIN K; METZ KA; LEDER LD; SACK H; SEEBER S
      RESPONSE-ADAPTED SEQUENTIAL COMBINATION CHEMOTHERAPY (CEBOPP VIML) FOLLOWED BY RADIOTHERAPY FOR BULKY AND ADVANCED-STAGE HODGKINS-DISEASE/

      Annals of oncology
    9. ALAMIN A; LENNARTZ K; RUNDE V; SEEBER S; OPALKA B; KLOKE O
      FREQUENCY OF CLONAL B-LYMPHOCYTES IN CHRONIC MYELOGENOUS LEUKEMIA EVALUATED BY FLUORESCENCE IN-SITU HYBRIDIZATION

      Cancer genetics and cytogenetics
    10. WELT A; ANHUF J; KRAWCZYK C; FOSSA A; STUSCHKE M; KLOKE O; SCHUTTE J; WESTERHAUSEN M; SACK H; SEEBER S; NOWROUSIAN MR
      INITIAL HIGH-DOSE SEQUENTIAL CHEMOTHERAPY IN THE TREATMENT OF AGGRESSIVE NON-HODGKIN LYMPHOMAS WITH RISK-FACTORS

      British Journal of Haematology
    11. KLOKE O; KUMMER G; SEEBER S
      RAPAMYCIN ANTAGONIZES INTERLEUKIN-6 MEDIATED GROWTH ARREST AND DIFFERENTIATION OF MYELOBLASTIC M1 CELLS

      Immunology letters
    12. KIRCH HC; PUTZER B; BROCKMANN D; ESCHE H; KLOKE O
      FORMATION OF THE EARLY-REGION-2 TRANSCRIPTION-FACTOR-1-RETINOBLASTOMA-PROTEIN (E2F-1-RB) TRANSREPRESSOR AND RELEASE OF THE RETINOBLASTOMA PROTEIN FROM NUCLEAR-COMPLEXES CONTAINING CYCLIN A IS INDUCED BY INTERFERON-ALPHA IN U937V CELLS BUT NOT IN INTERFERON-ALPHA-RESISTANT U937VRCELLS

      European journal of biochemistry
    13. OTTINGER HD; BEELEN DW; KASIMIRBAUER S; SCHULTEWOLTER T; REBMANN V; GOOS M; SCHEULEN ME; SEEBER S; SCHAEFER UW; GROSSEWILDE H; KLOKE O
      GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) REDUCES THE CAPACITY OFT-CELLS TO EXPRESS PRO-INFLAMMATORY CYTOKINES AND INCREASES SOLUBLE HLA PLASMA-LEVELS IN HUMANS

      Blood
    14. KLOKE O; NIEDERLE N; OPALKA B; HAWIG I; SEEBER S; BECHER R
      PROGNOSTIC IMPACT OF INTERFERON ALPHA-INDUCED CYTOGENETIC REMISSION IN CHRONIC MYELOGENOUS LEUKEMIA - LONG-TERM FOLLOW-UP

      European journal of haematology
    15. SIEBERT R; WILLERS CP; FOSSA A; KLOKE O; NOWROUSIAN MR; SEEBER S; OPALKA B
      ANALYSIS OF THE NOVEL CYCLIN-DEPENDENT KINASE-4 AND KINASE-6 INHIBITOR GENE P18 IN LYMPHOMA AND LEUKEMIA-CELL LINES

      Leukemia research
    16. BECHER R; KLOKE O; HAYUNGS J; HARTWICH G; BARTELS H; SZANTO J; WOLF E; ILLIGER HJ; HALABI S; RIECHE K; HERING KG; OHL S; DEDYCKER R; HUHN R; FISCHEDICK AR; HOFELER H; PIELKEN HJ; HAWIG I; HIRCHE H; SEEBER S
      EPIRUBICIN AND IFOSFAMIDE IN METASTATIC BREAST-CANCER

      Seminars in oncology
    17. THIELE J; KVASNICKA HM; NIEDERLE N; ZIRBES TK; SCHMIDT M; DAMMASCH J; MEUTER BR; LEDER LD; KLOKE O; DIEHL V; FISCHER R
      THE IMPACT OF INTERFERON VERSUS BUSULFAN THERAPY ON THE RETICULIN STAIN-MEASURED FIBROSIS IN CML - A COMPARATIVE MORPHOMETRIC STUDY ON SEQUENTIAL TREPHINE BIOPSIES

      Annals of hematology
    18. THIELE J; KVASNICKA HM; NIEDERLE N; KLOKE O; SCHMIDT M; LIENHARD H; ZIRBES T; MEUTER RB; LEDER LD; FISCHER R
      CLINICAL AND HISTOLOGICAL FEATURES RETAIN THEIR PROGNOSTIC IMPACT UNDER INTERFERON THERAPY OF CML - A PILOT-STUDY

      American journal of hematology
    19. KIRCH HC; PUTZER B; KUHLMANN S; BROCKMANN D; ESCHE H; KLOKE O
      CELL-DENSITY DEPENDENT GROWTH REDUCTION IN INTERFERON ALPHA-RESISTANTU937 VR UNRAVELS DIFFERENT MECHANISMS OF E2F(-1) INACTIVATION

      Experimental hematology
    20. BEELEN DW; GRAEVEN U; ELMAAGACLI AH; NIEDERLE N; KLOKE O; OPALKA B; SCHAEFER UW
      PROLONGED ADMINISTRATION OF INTERFERON-ALPHA IN PATIENTS WITH CHRONIC-PHASE PHILADELPHIA-CHROMOSOME-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA BEFORE ALLOGENEIC BONE-MARROW TRANSPLANTATION MAY ADVERSELY AFFECT TRANSPLANT OUTCOME

      Blood
    21. WANDL UB; BUTZLER R; NIEDERLE N; KLOKE O; MENGELKOCH B; BECHER R; SEEBER S; OPALKA B
      BCR-ABL-POSITIVE AND BCR-ABL-NEGATIVE CLONOGENIC CELLS IN CML PATIENTS UNDERGOING LONG-TERM INTERFERON TREATMENT

      Leukemia
    22. NIEDERLE N; MENGELKOCH B; DOBERAUER C; KLOKE O; WANDL U
      TREATMENT OF METASTATIC CARCINOID-TUMOR A ND THE CARCINOID-SYNDROME WITH RECOMBINANT INTERFERON-ALPHA

      Tumordiagnostik & Therapie
    23. KLOKE O
      COMBINATION THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA WITH INTERFERON-ALFA AND OTHER CYTOKINES

      Seminars in hematology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 31/05/20 alle ore 07:28:08